Aicuris reports positive Phase III pritelivir results for HSV patients
The trial enrolled and treated 101 immunocompromised patients with refractory or resistant HSV infection.
Clinical Trials
TransCode and Quantum Leap seek FDA approval for Phase IIa TTX-MC138 trial
DiMe unveils sDHT Adoption Navigator to advance clinical trial integration
Affinia receives FDA approval for Phase I/II trial for dilated cardiomyopathy
Invivyd aligns with FDA advice on LIBERTY Phase III Covid-19 trial
Biosion doses first patient in Phase Ia/Ib BSI-082 trial for solid tumours
SEQSTER and Praxis expand collaboration to expedite CNS disorder trials
Arcutis reports positive topline data in Zoryve trial for infant AD
